Zhaoyan New Drug
Profile and portfolio
Zhaoyan New Drug is the corporate venture arm of Zhaoyan New Drug Research Center, a pharmaceutical and biotech company. It invests from Series A to Series B. Sectors it names: biotech and life sciences, medical devices.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series A to Series B |
| Sectors | Biotech and life sciences, Medical devices |
| Geography | Asia |
Sources: S4 Wuxi Venture Capital: biomedicine fund completes multiple project investments; S1 Wuxi Venture Capital: Wuxi Capital and Zhaoyan set up a biomedicine industry fund.
Key facts
Fund vehicles
| Vehicle | Size | Year | Source |
|---|---|---|---|
| Wuxi Jinyi Fuxin Biomedicine Fund | CNY 5bn | 2024 | S1 |
Portfolio
Public sources name 3 portfolio companies.S4
Every company on the Zhaoyan New Drug list
3 companies, as named in the sources cited.S4 Read the firm's list.
- Kangyuan Bochuang
- Xingji Bio
- Xuanjing Bio
Official pages
Read the firm's own pages for current information.
- Website www.zhaoyan.com.cn
Sources
- S1Wuxi Venture Capital: Wuxi Capital and Zhaoyan set up a biomedicine industry fundPress
- S2Zhaoyan announcement: cooperation to set up an industry fund (Jul 2024)Filing
- S3Pencil News: Zhaoyan invests RMB 299M in a private fundPress
- S4Wuxi Venture Capital: biomedicine fund completes multiple project investmentsPress
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Zhaoyan New Drug or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.